 Antigens, CD
"Antigens, CD" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
| Descriptor ID |
D015703
|
| MeSH Number(s) |
D23.050.301.264.035 D23.101.100.110
|
| Concept/Terms |
Antigens, CD- Antigens, CD
- CD Antigens
- Cluster of Differentiation Markers
- Cluster of Differentiation Antigens
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD".
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD".
This graph shows the total number of publications written about "Antigens, CD" by people in this website by year, and whether "Antigens, CD" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 2 | 6 | | 1996 | 4 | 4 | 8 | | 1997 | 4 | 6 | 10 | | 1998 | 3 | 10 | 13 | | 1999 | 5 | 6 | 11 | | 2000 | 7 | 7 | 14 | | 2001 | 10 | 13 | 23 | | 2002 | 8 | 15 | 23 | | 2003 | 6 | 8 | 14 | | 2004 | 3 | 8 | 11 | | 2005 | 3 | 8 | 11 | | 2006 | 0 | 14 | 14 | | 2007 | 7 | 9 | 16 | | 2008 | 8 | 14 | 22 | | 2009 | 8 | 9 | 17 | | 2010 | 6 | 8 | 14 | | 2011 | 4 | 4 | 8 | | 2012 | 2 | 2 | 4 | | 2013 | 4 | 10 | 14 | | 2014 | 4 | 12 | 16 | | 2015 | 4 | 10 | 14 | | 2016 | 5 | 9 | 14 | | 2017 | 5 | 8 | 13 | | 2018 | 8 | 4 | 12 | | 2019 | 6 | 5 | 11 | | 2020 | 7 | 10 | 17 | | 2021 | 7 | 4 | 11 | | 2022 | 2 | 2 | 4 | | 2023 | 0 | 2 | 2 | | 2024 | 2 | 4 | 6 | | 2025 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Antigens, CD" by people in Profiles.
-
Weis AM, Bauer KM, Tang WW, Stephen-Victor E, Bell R, Brown DG, Ekiz HA, Tran V, Klag KA, Swanson EA, Barrios L, Harwood M, Hill JH, Ost KS, Gigic B, Schneider M, Ose J, Hardikar S, Toriola AT, Shibata D, Li CI, Figueiredo JC, Byrd DA, Siegel EM, Arnolds K, Lozupone C, Ulrich CM, O'Connell RM, Stephens WZ, Round JL. A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapy. Cell Rep. 2025 Sep 23; 44(9):116172.
-
Gallanis AF, Gamble LA, Oguz C, Samaranayake SG, Kedei N, Hernandez MO, Wong M, Tillo D, Green BL, McClelland P, Bowden C, Gullo I, Raffeld M, Xi L, Kelly M, Miettinen M, Quezado M, Kim SA, Blakely AM, Lack J, Heller T, Hernandez JM, Davis JL. Spatial Analysis of Hereditary Diffuse Gastric Cancer Reveals Indolent Phenotype of Signet Ring Cell Precursors. Mol Cancer Res. 2025 Aug 04; 23(8):699-709.
-
Kines KT, Fairchild HR, Elder AM, Cozzens LM, Strugar ZP, Wessells VM, Becks AR, Porter WW, Borges VF, Lyons TR. Aging-induced semaphorin 7a promotes TGF-ß1-mediated cell plasticity and breast tumor metastases. Cell Rep. 2025 Aug 26; 44(8):116042.
-
Niehaus C, Geanon D, Lietzau A, Jankovic M, Maucourant C, Maasoumy B, Sparrelid E, Wedemeyer H, Kahlhöfer J, Falk CS, Andrade IM, Ponzetta A, Björkström NK, Kraft ARM, Cornberg M, Strunz B. Origin of Hypofunctional CD103+ NK Cells in Cirrhosis-Associated Ascites. Eur J Immunol. 2025 Jun; 55(6):e51311.
-
Fasaye GA, Calzone K, Travis E, Gallanis AF, Gamble L, Davis JL. Association between proband characteristics and CDH1 cascade genetic testing uptake in at-risk relatives. J Genet Couns. 2025 Jun; 34(3):e70011.
-
Elder AM, Fairchild HR, Kines KT, Cozzens LM, Becks AR, Slansky JE, Anderson SM, Lyons TR. Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary involution and breast cancer. Cell Rep. 2025 May 27; 44(5):115676.
-
Day D, Ganju V, Chung K, Si L, Mao L, Aghmesheh M, Hoyer R, Brewin K, Zeng S, Zhang M, Lu Q, Jiang C, Ren F, Zhu Y, Guo J. First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors. Br J Cancer. 2025 Jun; 132(10):905-912.
-
Gurrea-Rubio M, Lin F, Wicha MS, Mao-Draayer Y, Fox DA. Ligands of CD6: roles in the pathogenesis and treatment of cancer. Front Immunol. 2024; 15:1528478.
-
Gallanis AF, Bowden C, Lopez R, Gamble LA, Samaranayake SG, Payne C, Snyder D, Fasaye GA, Joyce S, Broesamle R, Miao N, Miettinen M, Quezado M, Kim SA, Korman L, Heller T, Blakely AM, Hernandez JM, Davis JL. Lessons learned from 150 total gastrectomies for prevention of cancer. J Gastrointest Surg. 2025 Jan; 29(1):101889.
-
Ryan CE, Fasaye GA, Gallanis AF, Gamble LA, McClelland PH, Duemler A, Samaranayake SG, Blakely AM, Drogan CM, Kingham K, Patel D, Rodgers-Fouche L, Siegel A, Kupfer SS, Ford JM, Chung DC, Dowty JG, Sampson J, Davis JL. Germline CDH1 Variants and Lifetime Cancer Risk. JAMA. 2024 09 03; 332(9):722-729.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|